Sec Form 13D Filing - THE WOODBRIDGE COMPANY LIMITED filing for Thomson Reuters Corporation (TRI) - 2025-04-16

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to rows 8 and 10 above, includes 300,551,801 common shares of Thomson Reuters Corporation ("Common Shares") benefically owned by The Woodbridge Company Limited and subsidiaries and 12,957,040 Common Shares beneficially owned by the family of the late Roy H. Thomson, the first Lord Thomson of Fleet through various affiliated corporations.In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
In reference to row 13 above, based on 450,424,766 Common Shares outstanding as of March 31, 2025.


SCHEDULE 13D

 
THOMSON INVESTMENTS LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
THE WOODBRIDGE COMPANY LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1908720 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000706525 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1396164 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1925124 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
Woodbridge Investments Corporation
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927194 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927196 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927197 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927200 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927201 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927202 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927205 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927207 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927210 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
1000927211 Ontario Limited
 
Signature:/s/ John A. Forbes
Name/Title:CEO & President
Date:04/16/2025
 
KRT INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
DKRT FAMILY CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
DKRT INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000920847 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
MB FINANCE CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
TLT INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
TLT ISSUE HOLDCO A CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
TLT ISSUE HOLDCO B CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1761173 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
2677295 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000919995 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1754693 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
PJT INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000920848 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
PGF INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
PGF FAMILY CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
LCC INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921307 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921309 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000078931 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921299 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
LLD INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921297 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
JRD INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921305 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
2754783 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921303 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
GED INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921264 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921265 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000031857 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
SEG FAMILY CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
TCM INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921268 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
DYM INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921259 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
BG INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921257 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
ACG INVESTMENTS CORP.
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921253 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
2775329 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
 
1000921254 ONTARIO LIMITED
 
Signature:/s/ John A. Forbes
Name/Title:Attorney-in-fact
Date:04/16/2025
primary_doc.xml